GOBVIAMET

This brand name is authorized in Nigeria.

Active ingredients

The drug GOBVIAMET contains a combination of these active pharmaceutical ingredients (APIs):

1	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin
2	Sitagliptin UNII TS63EW8X6F - SITAGLIPTIN PHOSPHATE
	Sitagliptin is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors. The improvement in glycaemic control observed with this medicinal product may be mediated by enhancing the levels of active incretin hormones.
	Read more about Sitagliptin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101214	Tablet	Gobviamet 50/1000 TAB 1000 mg; 50 mg 5 x 10's	Film-coated tablets GOBVIAMET 50/1000 "SITAGLIPTIN 50 MG AND METFORMIN HYDROCHLORIDE BP 1000 MG -MICROCRYSTALLINE CELLULOSE -CARBOXYMETHYLCELLULOSE SODIUM -POVIDONE K30 -ISOPROPYL ALCOHOL -MAGNESIUM STEARATE -AEROSIL -CARBOXYMETHYLCELLULOSE SODIUM -INDION 234 IH " Drugs Imported Product 1pack, 5×10 Tablets 13-08-2024 GOBEN PHARMACY & GENERAL ENTERPRISES LTD, 62, Morocco Road Suleja, Niger State Nigeria. 08055485886 gobenpharmaceuticals@gmail.com HEALTHCARE FORMULATIONS PVT LTD. , C/8, Sardar Estate, Ajwa Road, Vadodara-390 019. (India)	27/03/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD07	Metformin and sitagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101214